GMPR2

guanosine monophosphate reductase 2

Basic information

Region (hg38): 14:24232422-24239242

Links

ENSG00000100938NCBI:51292OMIM:610781HGNC:4377Uniprot:Q9P2T1AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the GMPR2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the GMPR2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
16
clinvar
16
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 16 0 0

Variants in GMPR2

This is a list of pathogenic ClinVar variants found in the GMPR2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
14-24233215-C-A not specified Uncertain significance (Sep 29, 2023)3100528
14-24233522-C-T not specified Uncertain significance (Oct 21, 2021)2336356
14-24233557-G-A not specified Uncertain significance (Jan 26, 2022)2272963
14-24233594-G-T not specified Uncertain significance (Mar 06, 2023)2494492
14-24235798-G-T not specified Uncertain significance (Jul 09, 2021)2294841
14-24236040-A-G not specified Uncertain significance (Nov 19, 2022)2328338
14-24236090-G-A not specified Uncertain significance (Aug 13, 2021)2244871
14-24236102-A-G not specified Uncertain significance (Jun 17, 2024)3281734
14-24236112-G-A not specified Uncertain significance (Aug 13, 2021)2357744
14-24237260-C-T not specified Uncertain significance (Apr 28, 2022)2227941
14-24238260-T-C not specified Uncertain significance (Dec 19, 2023)3100529
14-24238268-G-C not specified Uncertain significance (May 17, 2023)2547025
14-24238360-C-T Uncertain significance (-)91918
14-24238396-C-T not specified Uncertain significance (Jun 18, 2021)2342648
14-24238402-A-C not specified Uncertain significance (May 18, 2023)2548428
14-24238600-G-A not specified Uncertain significance (Mar 19, 2024)3281735
14-24238635-G-C not specified Uncertain significance (Apr 22, 2024)3281736
14-24238704-A-G not specified Uncertain significance (Dec 21, 2023)3100526
14-24238720-G-A not specified Uncertain significance (Jan 17, 2023)2476143
14-24238735-G-A not specified Uncertain significance (Dec 03, 2021)3100527

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
GMPR2protein_codingprotein_codingENST00000420554 96821
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.03e-80.3211247310951248260.000381
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.8001772100.8450.00001062399
Missense in Polyphen6578.4410.82865912
Synonymous-0.2617875.11.040.00000383726
Loss of Function0.7051417.10.8168.50e-7213

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005700.000570
Ashkenazi Jewish0.000.00
East Asian0.0003890.000389
Finnish0.000.00
European (Non-Finnish)0.0005830.000583
Middle Eastern0.0003890.000389
South Asian0.00009810.0000980
Other0.0004950.000494

dbNSFP

Source: dbNSFP

Function
FUNCTION: Catalyzes the irreversible NADPH-dependent deamination of GMP to IMP. It functions in the conversion of nucleobase, nucleoside and nucleotide derivatives of G to A nucleotides, and in maintaining the intracellular balance of A and G nucleotides (PubMed:12009299, PubMed:12669231, PubMed:16359702, PubMed:22037469). Plays a role in modulating cellular differentiation (PubMed:12669231). {ECO:0000255|HAMAP- Rule:MF_03195, ECO:0000269|PubMed:12009299, ECO:0000269|PubMed:12669231, ECO:0000269|PubMed:16359702, ECO:0000269|PubMed:22037469}.;
Pathway
Purine metabolism - Homo sapiens (human);Metabolism of nucleotides;Metabolism;Nucleotide salvage;Purine salvage;Purine nucleotides nucleosides metabolism (Consensus)

Recessive Scores

pRec
0.249

Intolerance Scores

loftool
0.454
rvis_EVS
-0.18
rvis_percentile_EVS
40.16

Haploinsufficiency Scores

pHI
0.0865
hipred
Y
hipred_score
0.504
ghis
0.559

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.997

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Gmpr2
Phenotype

Gene ontology

Biological process
purine nucleobase metabolic process;purine ribonucleotide interconversion;purine-containing compound salvage;GMP metabolic process;oxidation-reduction process
Cellular component
cytosol;GMP reductase complex
Molecular function
GMP reductase activity;metal ion binding